295 related articles for article (PubMed ID: 36497109)
21. Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates.
Chea C; Lee DY; Kato J; Ishiwata-Endo H; Moss J
bioRxiv; 2023 Feb; ():. PubMed ID: 36945431
[TBL] [Abstract][Full Text] [Related]
22. ADP-ribosylhydrolase 3 (ARH3), not poly(ADP-ribose) glycohydrolase (PARG) isoforms, is responsible for degradation of mitochondrial matrix-associated poly(ADP-ribose).
Niere M; Mashimo M; Agledal L; Dölle C; Kasamatsu A; Kato J; Moss J; Ziegler M
J Biol Chem; 2012 May; 287(20):16088-102. PubMed ID: 22433848
[TBL] [Abstract][Full Text] [Related]
23. Role of a TRIM72 ADP-ribosylation cycle in myocardial injury and membrane repair.
Ishiwata-Endo H; Kato J; Tonouchi A; Chung YW; Sun J; Stevens LA; Zhu J; Aponte AM; Springer DA; San H; Takeda K; Yu ZX; Hoffmann V; Murphy E; Moss J
JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429362
[TBL] [Abstract][Full Text] [Related]
24. The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis.
Mashimo M; Onishi M; Uno A; Tanimichi A; Nobeyama A; Mori M; Yamada S; Negi S; Bu X; Kato J; Moss J; Sanada N; Kizu R; Fujii T
J Biol Chem; 2021; 296():100046. PubMed ID: 33168626
[TBL] [Abstract][Full Text] [Related]
25. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
Virág L
Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
[TBL] [Abstract][Full Text] [Related]
26. Activation of cell death mediated by apoptosis-inducing factor due to the absence of poly(ADP-ribose) glycohydrolase.
Zhou Y; Feng X; Koh DW
Biochemistry; 2011 Apr; 50(14):2850-9. PubMed ID: 21366272
[TBL] [Abstract][Full Text] [Related]
27. Mutations of the functional ARH1 allele in tumors from ARH1 heterozygous mice and cells affect ARH1 catalytic activity, cell proliferation and tumorigenesis.
Kato J; Vekhter D; Heath J; Zhu J; Barbieri JT; Moss J
Oncogenesis; 2015 Jun; 4(6):e151. PubMed ID: 26029825
[TBL] [Abstract][Full Text] [Related]
28. Reversibility of arginine-specific mono(ADP-ribosyl)ation: identification in erythrocytes of an ADP-ribose-L-arginine cleavage enzyme.
Moss J; Jacobson MK; Stanley SJ
Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5603-7. PubMed ID: 2994036
[TBL] [Abstract][Full Text] [Related]
29. Poly(ADP-ribose): PARadigms and PARadoxes.
Bürkle A; Virág L
Mol Aspects Med; 2013 Dec; 34(6):1046-65. PubMed ID: 23290998
[TBL] [Abstract][Full Text] [Related]
30. ADP-ribosylarginine hydrolases and ADP-ribosyltransferases. Partners in ADP-ribosylation cycles.
Moss J; Zolkiewska A; Okazaki I
Adv Exp Med Biol; 1997; 419():25-33. PubMed ID: 9193633
[TBL] [Abstract][Full Text] [Related]
31. Selective monitoring of the protein-free ADP-ribose released by ADP-ribosylation reversal enzymes.
Kasson S; Dharmapriya N; Kim IK
PLoS One; 2021; 16(6):e0254022. PubMed ID: 34191856
[TBL] [Abstract][Full Text] [Related]
32. Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease.
Prokhorova E; Agnew T; Wondisford AR; Tellier M; Kaminski N; Beijer D; Holder J; Groslambert J; Suskiewicz MJ; Zhu K; Reber JM; Krassnig SC; Palazzo L; Murphy S; Nielsen ML; Mangerich A; Ahel D; Baets J; O'Sullivan RJ; Ahel I
Mol Cell; 2021 Jun; 81(12):2640-2655.e8. PubMed ID: 34019811
[TBL] [Abstract][Full Text] [Related]
33. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic insights into the three steps of poly(ADP-ribosylation) reversal.
Rack JGM; Liu Q; Zorzini V; Voorneveld J; Ariza A; Honarmand Ebrahimi K; Reber JM; Krassnig SC; Ahel D; van der Marel GA; Mangerich A; McCullagh JSO; Filippov DV; Ahel I
Nat Commun; 2021 Jul; 12(1):4581. PubMed ID: 34321462
[TBL] [Abstract][Full Text] [Related]
35. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos).
Wang Y; Kim NS; Haince JF; Kang HC; David KK; Andrabi SA; Poirier GG; Dawson VL; Dawson TM
Sci Signal; 2011 Apr; 4(167):ra20. PubMed ID: 21467298
[TBL] [Abstract][Full Text] [Related]
36. Characterization of mammalian ADP-ribosylation cycles.
Okazaki IJ; Zolkiewska A; Takada T; Moss J
Biochimie; 1995; 77(5):319-25. PubMed ID: 8527484
[TBL] [Abstract][Full Text] [Related]
37. Mono(ADP-ribosyl)ation of poly(ADP-ribose)polymerase by cholera toxin.
Martinez M; Price SR; Moss J; Alvarez-Gonzalez R
Biochem Biophys Res Commun; 1991 Dec; 181(3):1412-8. PubMed ID: 1764092
[TBL] [Abstract][Full Text] [Related]
38. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
Lin KY; Huang D; Kraus WL
Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
[TBL] [Abstract][Full Text] [Related]
39. Distribution of protein poly(ADP-ribosyl)ation systems across all domains of life.
Perina D; Mikoč A; Ahel J; Ćetković H; Žaja R; Ahel I
DNA Repair (Amst); 2014 Nov; 23():4-16. PubMed ID: 24865146
[TBL] [Abstract][Full Text] [Related]
40. Amino acid specific ADP-ribosylation: substrate specificity of an ADP-ribosylarginine hydrolase from turkey erythrocytes.
Moss J; Oppenheimer NJ; West RE; Stanley SJ
Biochemistry; 1986 Sep; 25(19):5408-14. PubMed ID: 3778868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
